1. Home
  2. KRYS vs HEES Comparison

KRYS vs HEES Comparison

Compare KRYS & HEES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • HEES
  • Stock Information
  • Founded
  • KRYS 2015
  • HEES 1961
  • Country
  • KRYS United States
  • HEES United States
  • Employees
  • KRYS N/A
  • HEES N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • HEES Misc Corporate Leasing Services
  • Sector
  • KRYS Health Care
  • HEES Industrials
  • Exchange
  • KRYS Nasdaq
  • HEES Nasdaq
  • Market Cap
  • KRYS 3.6B
  • HEES 3.3B
  • IPO Year
  • KRYS 2017
  • HEES 2006
  • Fundamental
  • Price
  • KRYS $125.96
  • HEES $94.64
  • Analyst Decision
  • KRYS Strong Buy
  • HEES Buy
  • Analyst Count
  • KRYS 8
  • HEES 5
  • Target Price
  • KRYS $211.13
  • HEES $71.33
  • AVG Volume (30 Days)
  • KRYS 436.2K
  • HEES 682.5K
  • Earning Date
  • KRYS 05-06-2025
  • HEES 04-29-2025
  • Dividend Yield
  • KRYS N/A
  • HEES 1.16%
  • EPS Growth
  • KRYS 109.01
  • HEES N/A
  • EPS
  • KRYS 4.16
  • HEES 2.49
  • Revenue
  • KRYS $333,448,000.00
  • HEES $1,464,681,000.00
  • Revenue This Year
  • KRYS $48.66
  • HEES N/A
  • Revenue Next Year
  • KRYS $49.81
  • HEES $7.50
  • P/E Ratio
  • KRYS $30.31
  • HEES $37.96
  • Revenue Growth
  • KRYS 247.53
  • HEES N/A
  • 52 Week Low
  • KRYS $122.80
  • HEES $40.93
  • 52 Week High
  • KRYS $219.34
  • HEES $101.28
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 31.65
  • HEES 55.50
  • Support Level
  • KRYS $123.03
  • HEES $94.09
  • Resistance Level
  • KRYS $127.59
  • HEES $95.68
  • Average True Range (ATR)
  • KRYS 4.59
  • HEES 0.78
  • MACD
  • KRYS 0.39
  • HEES -0.00
  • Stochastic Oscillator
  • KRYS 18.15
  • HEES 43.61

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About HEES H&E Equipment Services Inc.

H&E Equipment Services Inc is an integrated equipment services company. The Company's construction rental fleet is among the industry's youngest with an equipment mix comprised of aerial work platforms, earthmoving, material handling, and other general and specialty lines. It rents, sells, and provides parts and services support for four core categories of equipment including hi-lift or aerial work platform equipment, cranes, earthmoving equipment, and industrial lift trucks. It engages in five principal business activities: equipment rentals; new equipment sales; sales of rental equipment; parts sales; and services. The majority of its revenue is derived from the equipment rentals segment.

Share on Social Networks: